Academic Journal

The value of dipyridamole echocardiography in risk stratification before vascular surgery

Bibliographic Details
Title: The value of dipyridamole echocardiography in risk stratification before vascular surgery
Authors: Sicari R, Picano E, Lusa AM, Salustri A, Ciavatti M, Del Rosso G, Kozakova M, FERRARI, MAURO, PEDRINELLI, ROBERTO, Pingitore A.
Source: European Heart Journal. 16:842-847
Publisher Information: Oxford University Press (OUP), 1995.
Publication Year: 1995
Subject Terms: Male, 2. Zero hunger, Heart Diseases, Rest, Dipyridamole, Middle Aged, Risk Assessment, 3. Good health, Electrocardiography, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Echocardiography, Preoperative Care, Exercise Test, Humans, Female, Prospective Studies, Vascular Surgical Procedures, Aged
Description: Patients undergoing major vascular surgery are at relatively high risk of cardiac events, and pharmacological stress echocardiography is increasingly used for peri-operative risk stratification.One hundred and twenty-one patients undergoing vascular surgery (age 65 +/- 7 years) were studied by dipyridamole echocardiography testing in six different centres. Of the total 136 patients, 15 were subsequently excluded because surgery was either cancelled (n = 8) or postponed pending cardiac revascularization (n = 7) because of the presence of a 'high-risk' stress echo response (identified 'a priori' as a positive dipyridamole echocardiography testing with a dipyridamole-time < 5 min and/or a peak wall motion score index > 2, upon scoring each segment from 1 = normal to 4 = dyskinetic in an 11-segment model).No major complications occurred during dipyridamole echocardiography testing. Technically adequate images were obtained in all patients; however, in one patient only the low dipyridamole dose (56 mg.kg-1 over 4 min) was given to limit side effects. Of the 121 patients undergoing surgery 28 (23%) had a positive test. Peri-operative events occurred in nine patients (8%): two deaths, two myocardial infarctions, five cases of unstable angina. Sensitivity and specificity of dipyridamole echocardiography testing for predicting cardiac events were 78% and 81%, respectively, with a positive predictive value of 25% and a negative predictive value of 98%. Dipyridamole echocardiography testing effectively singled out patients with, from those without, events, but neither clinical parameters, such as Detsky score, nor baseline echo parameters, such as resting wall motion score index or ejection fraction were able to distinguish between such patients.In conclusion, dipyridamole echocardiography testing is safe and well tolerated in patients undergoing major vascular surgery, and provides an effective pre-operative screening test for risk stratification of these patients mainly due to the extremely high negative predictive value. Stress echocardiography is a better discriminator than clinical and rest echocardiographic variables.
Document Type: Article
Language: English
ISSN: 1522-9645
0195-668X
DOI: 10.1093/oxfordjournals.eurheartj.a061004
Access URL: https://pubmed.ncbi.nlm.nih.gov/7588929
https://academic.oup.com/eurheartj/article-abstract/16/6/842/457449
https://europepmc.org/article/MED/7588929
https://pubmed.ncbi.nlm.nih.gov/7588929/
https://arpi.unipi.it/handle/11568/241337
https://www.ncbi.nlm.nih.gov/pubmed/7588929
https://hdl.handle.net/20.500.14243/4071
https://hdl.handle.net/11568/21843
Accession Number: edsair.doi.dedup.....2e76ada90c6de8a78b5ced87887233ee
Database: OpenAIRE
Description
ISSN:15229645
0195668X
DOI:10.1093/oxfordjournals.eurheartj.a061004